The House of Lords Science and Technology Committee is launching an inquiry into Innovation in the NHS: personalised medicine and AI.
BIVDA will be providing a submission and would be extremely grateful if members could provide evidence and their views in order to strengthen our response. This can be sent to ben.kemp@bivda.org.uk.
The inquiry will examine a number of topics:
- The current state of the science underpinning personalised medicine, the major gaps and existing possibilities, including the role of AI in personalised medicine.
- What research infrastructure is needed to support the development of personalised medicine and AI in the UK.
- How effective the UK is in translating its life sciences strengths into validated personalised medicine and AI tools and what can be done to remain competitive in this field.
- How proven innovations might be deployed across the NHS, and what key systematic barriers prevent or delay this.
- If regulatory frameworks are appropriate and proportionate, and where they could be improved.
- Whether current appraisal and commissioning models are appropriate for personalised medicine.
- What the Government needs to do to strengthen feedback loops between medical research, the life sciences industry and the NHS.
Submissions can be entered by 23:59 on Monday 20 April 2026 and we would invite member feedback up until 5pm on Thursday 16th April 2026.
